Diabetes RElated to Acute Pancreatitis and Its Mechanisms

Part of paid clinical trials in Los Angeles, California.

Sponsor
Milton S. Hershey Medical Center
Study ID
NCT05197920
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Study Details

The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).

Key Dates

Start date
Jan 14, 2022
Status verified
Nov 2025
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
800 participants (estimated)

Primary Outcome Measure

diabetes mellitus (DM) following a qualifying episode of acute pancreatitis (AP) [ Time Frame: any time during the 36-month longitudinal follow-up period ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Eleanor Chang
[email protected]
310-423-0747
Mark O Goodarzi, MD, PhD (PRINCIPAL_INVESTIGATOR)
Stephen J Pandol, MD (PRINCIPAL_INVESTIGATOR)
University of Southern CaliforniaLos AngelesCalifornia90033
Jessica Serna
[email protected]
323-409-6939
James L Buxbaum, MD (PRINCIPAL_INVESTIGATOR)
Stanford UniversityStanfordCalifornia94305
Lorena Pineda
[email protected]
650-723-4519
Walter Park, MD (PRINCIPAL_INVESTIGATOR)
Marina Basina, MD (PRINCIPAL_INVESTIGATOR)
University of FloridaGainesvilleFlorida32610-0214
Amber Bouton
[email protected]
352-273-9774
Chris Forsmark, MD (PRINCIPAL_INVESTIGATOR)
Steven J Hughes, MD (PRINCIPAL_INVESTIGATOR)
AdventHealthOrlandoFlorida32804
Gina Mercouffer
[email protected]
407-303-7106
Richard E Pratley, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Christine Nelson
[email protected]
312-695-4513
Rajesh N Keswani, MD, MS (PRINCIPAL_INVESTIGATOR)
University of Illinois at ChicagoChicagoIllinois60612
Haya Al Rashdan
[email protected]
312-413-0306
Cemal Yazici, MD, MSc (PRINCIPAL_INVESTIGATOR)
Brian Layden, MD (PRINCIPAL_INVESTIGATOR)
Indiana UniversityIndianapolisIndiana46202
Maureen Mullen-Montagano
[email protected]
317-274-7677
Evan L Fogel, MD (PRINCIPAL_INVESTIGATOR)
Carmella Evans-Molina, MD, PhD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins UniversityBaltimoreMaryland21205
Mahya Faghih
[email protected]
443-287-4680
Vikesh Singh, MD, MSc (PRINCIPAL_INVESTIGATOR)
Zhaoli Sun, MD, PhD (PRINCIPAL_INVESTIGATOR)
University of MinnesotaMinneapolisMinnesota55454
Heather Hodgkins
[email protected]
612-626-5293
Melena D Bellin, MD (PRINCIPAL_INVESTIGATOR)
Guru Trikudanathan, MD (PRINCIPAL_INVESTIGATOR)
Ohio State UniversityColumbusOhio43210
Zoe Krebs
[email protected]
614-685-6374
Phillip A Hart, MD (PRINCIPAL_INVESTIGATOR)
Georgios Papchristou, MD, PhD (PRINCIPAL_INVESTIGATOR)
University of PittsburghPittsburghPennsylvania15213
Shari Reynolds
[email protected]
412-383-0570
Dhiraj Yadav, MD, MPH (PRINCIPAL_INVESTIGATOR)
Frederico GS Toledo, MD (PRINCIPAL_INVESTIGATOR)
Benaroya Research InstituteSeattleWashington98101
Kim Varner
[email protected]
206-341-8936
Carla J Greenbaum, MD (PRINCIPAL_INVESTIGATOR)
Richard A Kozarek, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Medical Center· Los Angeles, CAUniversity of Southern California· Los Angeles, CAStanford University· Stanford, CAUniversity of Florida· Gainesville, FLAdventHealth· Orlando, FLNorthwestern University· Chicago, IL

Related Studies